Yuyu Pharma Information

Yuyu Pharma is a publicly traded pharmaceutical company listed on the Korean Stock Exchange(KRX: 000220). Founded in 1941, we have more than 80 years of experience developing, manufacturing, and distributing pharmaceuticals, medical devices, and food supplements. Yuyu Pharma has built a portfolio that spans prescription medicines, over-the-counter products, medical devices, and nutritional supplements — anchored by a commitment to quality, patient outcomes, and long-term partnership. Across three generations of continuous operation, we have earned the trust of clinicians, patients, and partners in Korea and abroad. Today, that heritage serves as the foundation for a broader ecosystem of health-focused ventures. Our Ecosystem Affiliate Yuyu Bio — A U.S.-based biotechnology company developing biologics for cats. A portfolio company of Magnify at CNSI at UCLA. Affiliate Mervyn's Petcare — A feline-first health supplement company. Platform Yuyu Venture Studio — Yuyu Pharma's internal platform for building and investing in next-generation health ventures. What We Stand For Science with patience. Manufacturing with discipline. Partnership with the long view. We work with global partners on manufacturing, licensing, and distribution across our therapeutic and consumer health portfolio. If your team is exploring opportunities in the Korean and Asian markets — or looking for a long-term partner with a proven track record — we invite you to get in touch. Follow this page for updates on our corporate milestones, product portfolio, partnership news, and ventures shaping the future of human and animal health.